Reducing the receipt of contraindicated medications in patients with Parkinson disease

BackgroundThe administration of antidopaminergic medications to patients with Parkinson’s disease (PD) can exacerbate symptoms, and in the hospital setting, can lead to complications and increased length of stay. Despite efforts to improve medication administration through provider education and pat...

Full description

Bibliographic Details
Main Authors: Caroline Goldin, Stefan Sillau, Elisa Worledge, Jarrett Bremmer, Robbie Cummins, Kathryn Tremolet de Villers, Michelle E. Fullard
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2023.1271072/full
_version_ 1827794678869655552
author Caroline Goldin
Stefan Sillau
Elisa Worledge
Jarrett Bremmer
Robbie Cummins
Kathryn Tremolet de Villers
Michelle E. Fullard
author_facet Caroline Goldin
Stefan Sillau
Elisa Worledge
Jarrett Bremmer
Robbie Cummins
Kathryn Tremolet de Villers
Michelle E. Fullard
author_sort Caroline Goldin
collection DOAJ
description BackgroundThe administration of antidopaminergic medications to patients with Parkinson’s disease (PD) can exacerbate symptoms, and in the hospital setting, can lead to complications and increased length of stay. Despite efforts to improve medication administration through provider education and patient-centered interventions, the problem persists, with an estimated 21–43% of hospitalized PD patients receiving dopamine blocking medications.MethodsIn this study, a best practice alert (BPA) was developed that was triggered when an antidopaminergic medication was ordered in the Emergency Department or hospital for a patient with a diagnosis of PD in the EMR. The primary outcomes were receipt of a contraindicated medication, length of stay (LOS) and readmission within 30 days. These outcomes were compared between the 12 months prior to the intervention and the 12 months post intervention. Data were also collected on admitting diagnosis, admitting service, neurology involvement and patient demographics.ResultsFor pre-intervention inpatient encounters, 18.3% involved the use of a contraindicated medication. This was reduced to 9.4% of all inpatient encounters for PD patients in the first 3 months post-intervention and remained lower at 13.3% for the full 12 months post-intervention. The overall rate of contraindicated medication use was low for ED visits at 4.7% pre-intervention and 5.7% post-intervention. Receipt of a contraindicated medication increased the risk of a longer length of stay, both before and after the intervention, but did not significantly affect 30-day readmission rate.ConclusionAn EMR BPA decreased the use of contraindicated medications for PD patients in the hospital setting, especially in the first 3 months. Strategies are still needed to reduce alert fatigue in order to maintain initial improvements.
first_indexed 2024-03-11T18:38:16Z
format Article
id doaj.art-ddcdf3cefed7471ca708b46366b1be87
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-03-11T18:38:16Z
publishDate 2023-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-ddcdf3cefed7471ca708b46366b1be872023-10-12T16:31:17ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652023-10-011510.3389/fnagi.2023.12710721271072Reducing the receipt of contraindicated medications in patients with Parkinson diseaseCaroline Goldin0Stefan Sillau1Elisa Worledge2Jarrett Bremmer3Robbie Cummins4Kathryn Tremolet de Villers5Michelle E. Fullard6Department of Neurology, Ochsner Medical Center, New Orleans, LA, United StatesDepartment of Neurology, University of Colorado, Aurora, CO, United StatesUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Denver Health, Denver, CO, United StatesBaptist Health, Jacksonville, FL, United StatesDepartment of Neurology, University of Colorado, Aurora, CO, United StatesDepartment of Pharmacy, University of Colorado Hospital, Aurora, CO, United StatesDepartment of Neurology, University of Colorado, Aurora, CO, United StatesBackgroundThe administration of antidopaminergic medications to patients with Parkinson’s disease (PD) can exacerbate symptoms, and in the hospital setting, can lead to complications and increased length of stay. Despite efforts to improve medication administration through provider education and patient-centered interventions, the problem persists, with an estimated 21–43% of hospitalized PD patients receiving dopamine blocking medications.MethodsIn this study, a best practice alert (BPA) was developed that was triggered when an antidopaminergic medication was ordered in the Emergency Department or hospital for a patient with a diagnosis of PD in the EMR. The primary outcomes were receipt of a contraindicated medication, length of stay (LOS) and readmission within 30 days. These outcomes were compared between the 12 months prior to the intervention and the 12 months post intervention. Data were also collected on admitting diagnosis, admitting service, neurology involvement and patient demographics.ResultsFor pre-intervention inpatient encounters, 18.3% involved the use of a contraindicated medication. This was reduced to 9.4% of all inpatient encounters for PD patients in the first 3 months post-intervention and remained lower at 13.3% for the full 12 months post-intervention. The overall rate of contraindicated medication use was low for ED visits at 4.7% pre-intervention and 5.7% post-intervention. Receipt of a contraindicated medication increased the risk of a longer length of stay, both before and after the intervention, but did not significantly affect 30-day readmission rate.ConclusionAn EMR BPA decreased the use of contraindicated medications for PD patients in the hospital setting, especially in the first 3 months. Strategies are still needed to reduce alert fatigue in order to maintain initial improvements.https://www.frontiersin.org/articles/10.3389/fnagi.2023.1271072/fullParkinson ‘s diseasebest practice alertquality improvementelectronic medical recordcontraindicated medications
spellingShingle Caroline Goldin
Stefan Sillau
Elisa Worledge
Jarrett Bremmer
Robbie Cummins
Kathryn Tremolet de Villers
Michelle E. Fullard
Reducing the receipt of contraindicated medications in patients with Parkinson disease
Frontiers in Aging Neuroscience
Parkinson ‘s disease
best practice alert
quality improvement
electronic medical record
contraindicated medications
title Reducing the receipt of contraindicated medications in patients with Parkinson disease
title_full Reducing the receipt of contraindicated medications in patients with Parkinson disease
title_fullStr Reducing the receipt of contraindicated medications in patients with Parkinson disease
title_full_unstemmed Reducing the receipt of contraindicated medications in patients with Parkinson disease
title_short Reducing the receipt of contraindicated medications in patients with Parkinson disease
title_sort reducing the receipt of contraindicated medications in patients with parkinson disease
topic Parkinson ‘s disease
best practice alert
quality improvement
electronic medical record
contraindicated medications
url https://www.frontiersin.org/articles/10.3389/fnagi.2023.1271072/full
work_keys_str_mv AT carolinegoldin reducingthereceiptofcontraindicatedmedicationsinpatientswithparkinsondisease
AT stefansillau reducingthereceiptofcontraindicatedmedicationsinpatientswithparkinsondisease
AT elisaworledge reducingthereceiptofcontraindicatedmedicationsinpatientswithparkinsondisease
AT jarrettbremmer reducingthereceiptofcontraindicatedmedicationsinpatientswithparkinsondisease
AT robbiecummins reducingthereceiptofcontraindicatedmedicationsinpatientswithparkinsondisease
AT kathryntremoletdevillers reducingthereceiptofcontraindicatedmedicationsinpatientswithparkinsondisease
AT michelleefullard reducingthereceiptofcontraindicatedmedicationsinpatientswithparkinsondisease